Soleno Therapeutics (SLNO)

• Market cap: $2.23B
• 1 day: -3.4%
• 5 days: -7.69%
• 1 month: -20.12%
• 3 months: -35.37%
• 6 months: -49.81%
• Year to date: -11.94%
• 1 year: -3.53%
• 5 years: 20.41%
• 10 years: -58.97%
• Sector: Healthcare
• Industry: Biotechnology

About: Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Employees: 152